Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Bicycle Therapeutics plc (BCYC) has a Wall Street consensus price target of $11.00, based on estimates from 21 covering analysts. With the stock currently trading at $5.73, this represents a potential upside of +92.0%. The company has a market capitalization of $111M.
Analyst price targets range from a low of $10.00 to a high of $12.00, representing a 18% spread in expectations. The median target of $11.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 17 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 0 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, BCYC trades at a trailing P/E of -2.0x. Analysts expect EPS to grow -3.1% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how BCYC stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonThe consensus Wall Street price target for BCYC is $11, representing 92.0% upside from the current price of $5.73. With 21 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
BCYC has a consensus rating of "Buy" based on 21 Wall Street analysts. The rating breakdown is predominantly bullish, with 17 Buy/Strong Buy ratings. The consensus 12-month price target of $11 implies 92.0% upside from current levels.
BCYC's current price is $5.73 with a consensus target of $11 (92.0% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $12 for BCYC, while the most conservative target is $10. The consensus of $11 represents the median expectation. These targets typically reflect 12-month expectations.
BCYC is well covered by analysts, with 21 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 17 have Buy ratings, 4 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month BCYC stock forecast based on 21 Wall Street analysts shows a consensus price target of $11, with estimates ranging from $10 (bear case) to $12 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on BCYC, with a "Buy" consensus rating and $11 price target (92.0% upside). 17 of 21 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
BCYC analyst price targets range from $10 to $12, a 18% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $11 consensus represents the middle ground.